Adolescent alcohol exposure increases orexin-A/hypocretin-1 in the anterior hypothalamus

被引:4
|
作者
Amodeo, Leslie R. [3 ]
Liu, Wen [2 ]
Wills, Derek N. [1 ]
Vetreno, Ryan P. [2 ]
Crews, Fulton T. [2 ]
Ehlers, Cindy L. [1 ]
机构
[1] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA
[2] Univ N Carolina, Bowles Ctr Alcohol Studies, Sch Med, Chapel Hill, NC 27599 USA
[3] Calif State Univ San Bernardino, Dept Psychol, San Bernardino, CA 92407 USA
基金
美国国家卫生研究院;
关键词
adolescence; hypocretin/orexin; hypothalamus; ADMISSION PREDICTS RELAPSE; BEHAVIORAL SLEEP DISORDERS; ETHANOL VAPOR EXPOSURE; MEDIAL PREOPTIC AREA; OREXIN-A; PARAVENTRICULAR NUCLEUS; LIFETIME DIAGNOSIS; CIRCADIAN-RHYTHMS; HYPOCRETIN OREXIN; 1ST INTOXICATION;
D O I
10.1016/j.alcohol.2020.06.003
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Adolescence is a time of marked changes in sleep, neuromaturation, and alcohol use. While there is substantial evidence that alcohol disrupts sleep and that disrupted sleep may play a role in the development of alcohol use disorders (AUD), there is very little known about the brain mechanisms underlying this phenomenon. The orexin (also known as hypocretin) system is fundamental for a number of homeostatic mechanisms, including the initiation and maintenance of wakefulness that may be impacted by adolescent alcohol exposure. The current study investigated the impact of adolescent ethanol exposure on adult orexin-A/hypocretin-1 immunoreactive (orexin-A + IR) cells in hypothalamic nuclei in two models of adolescent intermittent ethanol (AIE) exposure. Both models assess adult hypothalamic orexin following either an AIE vapor exposure paradigm, or an AIE intragastric gavage paradigm during adolescence. Both AIE exposure models found that binge levels of ethanol intoxication during adolescence significantly increased adult orexin-A + IR expression in the anterior hypothalamic nucleus (AHN). Further, both AIE models found no change in orexin-A + IR in the posterior hypothalamic area (PH), perifornical nucleus (PeF), dorsomedial hypothalamic nucleus dorsal part (DMD) or lateral hypothalamic area (LH). However, AIE vapor exposure reduced orexin-A + IR in the paraventricular nucleus (PVN), but AIE gavage exposure did not. These findings suggest that the AHN orexinergic system is increased in adults following binge-like patterns of intoxication during adolescence. Altered adult AHN orexin could contribute to long-lasting changes in sleep. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 50 条
  • [1] The significance of CSF hypocretin-1 (Orexin-A) measurement in pediatric and adolescent neurologic disorders
    Arii, J
    Kanbayashi, T
    Sawaishi, Y
    Yano, T
    Kimura, S
    Hishikawa, Y
    Takahashi, Y
    Shimizu, Y
    Tanabe, Y
    Nishino, S
    [J]. SLEEP, 2003, 26 : A129 - A130
  • [2] Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome
    Allen, RP
    Mignot, E
    Ripley, B
    Nishino, S
    Earley, CJ
    [J]. NEUROLOGY, 2002, 59 (04) : 639 - 641
  • [3] Hypocretin-1/orexin-A activates subfornical organ neurons of rats
    Ono, Kentaro
    Kai, Aya
    Honda, Eiko
    Inenaga, Kiyotoshi
    [J]. NEUROREPORT, 2008, 19 (01) : 69 - 73
  • [4] CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage
    Dohi, K.
    Ripley, B.
    Fujiki, N.
    Nakamachi, T.
    Ohtaki, H.
    Shioda, S.
    Aruga, T.
    Nishino, S.
    [J]. REGULATORY PEPTIDES, 2006, 135 (03) : 193 - 193
  • [5] EVALUATION OF COMMERCIAL RIA AND ELISA FOR MEASURING CSF OREXIN-A (HYPOCRETIN-1)
    Ono, T.
    [J]. SLEEP, 2017, 40 : A247 - A247
  • [6] CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH)
    Dohi, Kenji
    Ripley, Beth
    Fujiki, Nobuhiro
    Ohtaki, Hirokazu
    Yamamoto, Takefumi
    Goto, Yoko
    Nakamachi, Tomoya
    Shioda, Seiji
    Aruga, Tohru
    Nishino, Seiji
    [J]. REGULATORY PEPTIDES, 2008, 145 (1-3) : 60 - 64
  • [7] Decreased CSF hypocretin-1 (Orexin-A) level in narcolepsy without cataplexy
    Oka, Y
    Inoue, Y
    Kanbayashi, T
    Ikeda, A
    Shimizu, T
    Shibasaki, H
    [J]. SLEEP, 2003, 26 : A282 - A282
  • [8] Intranasal Drug Targeting of Hypocretin-1 (Orexin-A) to the Central Nervous System
    Dhuria, Shyeilla V.
    Hanson, Leah R.
    Frey, William H., II
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (07) : 2501 - 2515
  • [9] CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH)
    Dohi, K
    Ripley, B
    Fujiki, N
    Ohtaki, H
    Shioda, S
    Aruga, T
    Nishino, S
    [J]. PEPTIDES, 2005, 26 (11) : 2339 - 2343
  • [10] Functional opioid pathways are necessary for hypocretin-1 (orexin-A)-induced feeding
    Sweet, DC
    Levine, AS
    Kotz, CM
    [J]. PEPTIDES, 2004, 25 (02) : 307 - 314